Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Vitae Pharmaceuticals Company Profile

10:50 EDT 29th July 2014 | BioPortfolio

Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds in human clinical trials, a broad portfolio of late stage preclinical programs and an underlying pipeline of discovery programs. Vitae's goal is to discover, develop and commercialize innovative new medicines that will be best-in-class for important disease areas, such as cardiovascular diseases, cancer and dermatology.We are focused on the development of compounds for high value, well validated biological targets. In our discovery and development processes, we seek to leverage available existing clinical and / or preclinical knowledge to efficiently and effectively create novel drug candidates that can address clear unmet therapy needs. Vitae's unique product engine combines the drug discovery skills of proven, deeply experienced drug hunters with state-of-the-art proprietary drug design technologies. This integrated and entrepreneurial approach improves the quality and innovativeness of the compounds we discover, while dramatically shortening the time required to bring them to the clinic.We have demonstrated the ability to rapidly advance novel compounds into clinical development, as Vitae now has clinical candidates in three therapeutic areas, two of which are in clinical studies and a pipeline of additional promising compounds.


502 West Office Center
Drive Fort Washington
United States of America


Phone: (215) 461-2000
Fax: (215) 461-2006

News Articles [10 Associated News Articles listed on BioPortfolio]

Vitae May Look To Public Markets After Nearly A Decade Of Self-Sustained Growth

Alzheimer’s collaboration with Boehringer Ingelheim heads into the clinic, triggering a $14 million milestone payment to Vitae. But as the discovery specialist focuses more on autoimmune conditions...

Vitae partner Boehringer takes BACE inhibitor into the clinic

Vitae president and CEO Jeffrey Hatfield acknowledged that the Fort Washington, Pennsylvania-based firm and Boehringer have entered a somewhat crowded field, since several BACE inhibitors already are...

Vitae Pharma earns $14 million milestone from Boehringer Ingelheim in Alzheimer's collaboration

US clinical-stage biotech firm Vitae Pharmaceuticals says it has earned a $14 million milestone payment from German family-owned drug major Boehringer Ingelheim for its initiation of a Phase I clinica...

Vitae Pharmaceuticals Earns $14 Million Milestone Payment from Boehringer Ingelheim in Alzheimer's Collaboration

FORT WASHINGTON, Pa., Feb. 20, 2014 /PRNewswire/ -- Vitae Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and advancing novel, small molecule, best-in-class co...

Vitae Pharmaceuticals Inc management update

Vitae Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Vitae Pharmaceuticals, Inc. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-05-29. This 32-page report i...

Patients: Our Purpose, Our Partners

This blog was written by Jeff Hatfield, CEO of Vitae Pharmaceuticals, as part of the “From the Trenches” feature of LifeSciVC. My first experience in this life sciences industry, many years ago,...

Vitae Pharmaceuticals Adds to Leadership Team With Appointment of Arthur Fratamico as Chief Business Officer, Richard Morris as Chief Financial Officer

FORT WASHINGTON, Pa., July 8, 2014 (GLOBE NEWSWIRE) -- Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on discovering and developing small molecule drugs, today announced...

Drugs and Medications [0 Results]


PubMed Articles [9 Associated PubMed Articles listed on BioPortfolio]

Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe.

The medicinal chemistry and biomedical applications of gold complexes have been intensively studied over the last decades. Some complexes have been used for the treatment of rheumatoid arthritis, and...

The physiologist Ewald Hering (1834-1918): Curriculum vitae.

TheLumen Vitae award in the psychology of religion.

Samuel Goldflam (1852-1932) - promoter of modern neurology and his contribution to urology.

The work of Samuel Goldflam is well known among urologists and nephrologists but his name also holds a special significance to the development of several specialist disciplines of modern medicine. A s...

Grant Writing 101.

Writing a grant is a hefty undertaking. Start by surrounding yourself with a successful mentor and accompanying team with a good track record. Get organized, select clear goals and objectives to your...

Clinical Trials [0 Results]


Companies [7 Associated Companies listed on BioPortfolio]

Vitae Pharmaceuticals, Inc.

Vitae Pharmaceuticals is a development-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large markets, including...

Vitae Pharmaceuticals

Vitae Pharmaceuticals is an emerging pharmaceutical company with two compounds in human clinical trials, a broad portfolio of late stage preclinical programs and an underlying pipeline of discovery pr...

CV Index

The CV Index provides a permanent, web presence & management centre for your Curriculum Vitae (Resume), which is freely searchable on our powerful CVs search engine, wherever you are in the world. Ch...


Our Profile represents an introductory overview of the key facts investors need to know about BB MEDTECH. The various ticker symbols are also available here. Click on Board of Directors and Management...

BitTech, Inc

BitTech, Inc. is a biotechnology company that focuses on the identification and initiation of research which has the potential to lead to enabling technology. BitTech was founded by Grant A. Bitter,...

More Information about "Vitae Pharmaceuticals" on BioPortfolio

We have published hundreds of Vitae Pharmaceuticals news stories on BioPortfolio along with dozens of Vitae Pharmaceuticals Clinical Trials and PubMed Articles about Vitae Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vitae Pharmaceuticals Companies in our database. You can also find out about relevant Vitae Pharmaceuticals Drugs and Medications on this site too.

Search BioPortfolio:

Relevant Topics

Cardiovascular disease (CVD)
Latest News Clinical Trials Research Drugs Reports Corporate
Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina and heart attack), heart failure, congenital heart disease and stroke. It is also known as heart and circulatory disease. Coron...

Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spre...


Corporate Database Quicklinks

Searches Linking to this Company Record